Extra Space Storage, Inc. vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Extra Space Storage, Inc. trades at $133.26 (market cap $27.82B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B). The key difference: Extra Space Storage, Inc. is far larger — about 12.2× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Extra Space Storage, Inc. pays a 4.92% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| EXR | SLS | |
|---|---|---|
Market Cap | $27.82B | $2.28B |
Volume | 1,465,973 | 3,128,960 |
Sector | Real Estate | Health |
52-Week High | $152.85 | $15.46 |
52-Week Low | $126.67 | $1.39 |
Typical Hold Time | 108 Days | — |
Enterprise Value | $41.54B | $2.15B |
Dividend Yield | 4.92% | — |
Signals from Pluang's Aura AI — not financial advice
Extra Space Storage (EXR) trades at $133.12, down 0.58% on the day, amid a bearish technical signal. The company shows strong fundamentals with revenue of $3.38B in 2025 and a net income margin of 27.79%. Recent earnings have consistently beaten expectations, and a leadership transition is set for 2027. Analyst consensus is split evenly between Buy and Hold, with a price target of $158.33, suggesting potential upside.
The outlook is balanced: solid operational performance and dividend payments support the stock, but high valuation ratios and a bearish technical trend present near-term risks. Investors should weigh the company's steady growth against market sentiment and debt levels.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Extra Space Storage is a fully integrated real estate investment trust that owns, operates, and manages almost 2,100 self-storage properties in 41 states, with over 160 million net rentable square feet of storage space. Of these properties, approximately one half is wholly owned, while some facilities are owned through joint ventures and others are owned by third parties and managed by Extra Space Storage in exchange for a management fee.
Read more on EXR →SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →